| 摘要: |
| 通过淋巴细胞杂交瘤技术或基因工程技术制备单克隆抗体药物，已经成为生物制药领域的一个重要方面，特别是对抗肿瘤单克隆抗体药物的研究已获得了重要进展。多年来，许多研究证实了抗肿瘤草克隆抗体药物的作用，为其应用于肿瘤治疗提供了重要依据。文章就抗肿瘤单克隆抗体药物的种类、制备、应用及存在问题进行了综述，并对其应用前景进行了展望。 |
| 关键词: 单克隆抗体 单克隆抗体药物 肿瘤 |
| DOI： |
| 分类号: |
| 基金项目:国家自然科学基金（30371067）；霍英东教育基金（91033） |
|
| Advance on monoclonal antibody therapeutics for tumor |
|
|
| Abstract: |
| Monoclonal antibody therapeutics prepared by techniques of lymphocytic hybridoma and gene engineering has been an important role in biotechnological medicines.Especially for tumor,a great deal of progress has been made.The antitumor effects of monoclonal antibody therapeutics have been determined by a lot of researches for several years and provided crucial base for tumor therapy.In the following paper,the types,preparation,usage and limitation of monoclonal antibody therapeutics for tumor were summarized and the application prospect was forecasted. |
| Key words: monoclonal antibody monoclonal antibody therapeutics tumor |
